These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7361721)

  • 1. Factor X assays using chromogenic substrate S-2222.
    Girolami A; Saggin L; Boeri G
    Am J Clin Pathol; 1980 Mar; 73(3):400-2. PubMed ID: 7361721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanized amidolytic technique for determination of factor X and factor-X antigen, and its application to patients being treated with oral anticoagulants.
    van Wijk EM; Kahlé LH; ten Cate JW
    Clin Chem; 1980 Jun; 26(7):885-90. PubMed ID: 7379310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A family with heterozygous factor X Friuli defect outside Friuli.
    Girolami A; Lazzarin M; Procidano M; Luzzatto G
    Blut; 1983 Mar; 46(3):149-54. PubMed ID: 6824795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of hereditary and acquired factor X deficiencies by combined immunochemical and functional analyses.
    Fair DS; Edgington TS
    Br J Haematol; 1985 Feb; 59(2):235-48. PubMed ID: 3970856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel factor X deficiency. Normal partial thromboplastin time and associated spindle cell thymoma.
    Nora RE; Bell WR; Noe DA; Sholar PW
    Am J Med; 1985 Jul; 79(1):122-6. PubMed ID: 4014297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological properties of the thromboplastins and plasmas included in the ICTH/ICSH collaborative study on prothrombin time standardization.
    Loeliger EA; van Halem-Visser LP
    Thromb Haemost; 1979 Dec; 42(4):1115-27. PubMed ID: 542924
    [No Abstract]   [Full Text] [Related]  

  • 7. Factor X deficiency in a cat.
    Gookin JL; Brooks MB; Catalfamo JL; Bunch SE; Muñana KR
    J Am Vet Med Assoc; 1997 Sep; 211(5):576-9. PubMed ID: 9290823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative one-stage assays for factors V and X.
    Babson AL; Flanagan ML
    Am J Clin Pathol; 1975 Dec; 64(6):817-9. PubMed ID: 1202939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogenic substrate (S-2222) factor X assays in the follow-up of coumarin treated patients. No advantage over prothrombin time and/or thrombotest.
    Girolami A; Saggin L; Gazzetta R; Saltarin P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):610-6. PubMed ID: 6170557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromogenic substrate (S-2238) prothrombin assay in prothrombin deficiencies and abnormalities. Lack of identity with clotting assays in congenital dysprothrombinemias.
    Girolami A; Patrassi G; Toffanin F; Saggin L
    Am J Clin Pathol; 1980 Jul; 74(1):83-7. PubMed ID: 7395819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of the factor X Friuli variant.
    Fair DS; Revak DJ; Hubbard JG; Girolami A
    Blood; 1989 Jun; 73(8):2108-16. PubMed ID: 2471558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital factor X deficiency in Japan.
    Mori K; Sakai H; Nakano N; Suzuki S; Sugai K; Hisa S; Goto Y
    Tohoku J Exp Med; 1981 Jan; 133(1):1-19. PubMed ID: 7233424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet aggregation and adhesiveness in classical factor X deficiency and in the abnormal factor X (factor X Friuli) coagulation disorder.
    Girolami A; Fabris F; Peruffo R; Coser P
    Acta Haematol; 1976; 56(5):307-13. PubMed ID: 826088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of several tissue thromboplastins on the activation of the abnormal factor X (factor X Friuli).
    Girolami A; Lazzarin M; Molaro G
    Thromb Diath Haemorrh; 1972 Jul; 27(3):535-42. PubMed ID: 4197046
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of human brain thromboplastin and Russell's viper venom on normal and abnormal human blood serum.
    Ivanovic-Zuvic N; Honorato R
    Acta Physiol Lat Am; 1973; 23(2):124-31. PubMed ID: 4747719
    [No Abstract]   [Full Text] [Related]  

  • 16. An evaluation of chromogenic substrates in the control of oral anticoagulant therapy.
    Latallo ZS; Thomson JM; Poller L
    Br J Haematol; 1981 Feb; 47(2):307-18. PubMed ID: 7470395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor X Padua: a 'new' congenital factor X abnormality with a defect only in the extrinsic system.
    Girolami A; Vicarioto M; Ruzza G; Cappellato G; Vergolani A
    Acta Haematol; 1985; 73(1):31-6. PubMed ID: 3923765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplified performance of amidolytic factor X assay.
    Egberg N; Heedman PA
    Thromb Res; 1982 Mar; 25(5):437-40. PubMed ID: 7071814
    [No Abstract]   [Full Text] [Related]  

  • 19. [Congenital factor X deficiency, the Prower-Stuart deficiency].
    Martinić P
    Bilt Hematol Transfuz; 1981; 9(1-3):69-75. PubMed ID: 7349760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A further inherited variant of coagulation factor X.
    Parkin JD; Madaras F; Sweet B; Castaldi PA
    Aust N Z J Med; 1974 Dec; 4(6):561-4. PubMed ID: 4533945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.